Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:899-900 (26 April), doi:10.1136/bmj.39535.650336.BE (published 16 April 2008)
Rapid screening is no more effective at reducing acquisition than conventional screening
| The first 150 words of the full text of this article appear below. |
Controversy about the effectiveness of screening for meticillin resistant Staphylococcus aureus (MRSA) stems from the scarcity of robust data from controlled studies. Typically, studies supporting screening have used multiple control measures to curtail hospital outbreaks of MRSA and have lacked control groups.1 The effectiveness of screening depends on key factors including compliance with and sensitivity of screening, capacity to isolate or form cohorts out of identified MRSA carriers, efficacy of decolonisation regimens, and compliance with standard infection control precautions (such as hand hygiene, aseptic procedures when handling vulnerable sites or devices, and prophylaxis).2 In the accompanying study, Jeyaratnam and colleagues report a randomised controlled trial of the effect of rapid screening for MRSA on acquisition of MRSA on hospital general wards in the United Kingdom.3
In some healthcare systems—for example, in the Netherlands—MRSA screening has helped maintain low MRSA colonisation and infection rates. However, in MRSA endemic settings in the
Mark H Wilcox, professor of medical microbiology
1 Leeds Teaching Hospitals and University of Leeds, Department of Microbiology, Old Medical School, Leeds General Infirmary, Leeds LS1 3EX
Mark.Wilcox@Leedsth.nhs.uk
Read all Rapid Responses